CAS: 59831-64-0 - Milenperone
Formula:C22H23ClFN3O2
InChI:InChI=1S/C22H23ClFN3O2/c23-17-4-7-20-19(14-17)25-22(29)27(20)11-1-10-26-12-8-16(9-13-26)21(28)15-2-5-18(24)6-3-15/h2-7,14,16H,1,8-13H2,(H,25,29)
InChI key:InChIKey=DBESQBZOXMCXPV-UHFFFAOYSA-N
SMILES:O=C1NC2=CC(Cl)=CC=C2N1CCCN3CCC(C(=O)C4=CC=C(F)C=C4)CC3
- Synonyms:
- 261-947-5
- 2H-Benzimidazol-2-one, 5-chloro-1-[3-[4-(4-fluorobenzoyl)-1-piperidinyl]propyl]-1,3-dihydro-
- 5-Chloro-1-[3-[4-(4-fluorobenzoyl)-1-piperidinyl]propyl]-1,3-dihydro-2H-benzimidazol-2-one
- 5-Chloro-1-{3-[4-(4-fluorobenzoyl)piperidin-1-yl]propyl}-1,3-dihydro-2H-benzimidazol-2-one
- 59831-64-0
- R 34009
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Milenperone REF: 3D-FM26004CAS: 59831-64-0 | Min. 95% | 184.00 €~1,216.00 € | Wed 22 Jan 25 | |
Milenperone REF: TR-M344300CAS: 59831-64-0 | - - - | 324.00 €~2,139.00 € | Fri 21 Feb 25 | |
Milenperone REF: TM-T25813CAS: 59831-64-0 | 98.09% - 99.38% | 277.00 €~2,329.00 € | Mon 03 Mar 25 |
Milenperone
CAS:59831-64-0
Neuroleptic agent
Formula:
C22H23ClFN3O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
415.89 g/mol
Ref: 3D-FM26004
1mg | 184.00 € | ||
2mg | 217.00 € | ||
5mg | 406.00 € | ||
10mg | 633.00 € | ||
25mg | 1,216.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
Milenperone
Controlled ProductCAS:59831-64-0
Applications A specific serotonin-S2 antagonist. A selective drug for the control of behavioral disorders in …
Formula:
C22H23ClFN3O2
Color and Shape:
Neat
Molecular weight:
415.89
Ref: TR-M344300
5mg | 324.00 € | ||
50mg | 2,139.00 € |
Estimated delivery in United States, on Friday 21 Feb 2025
Milenperone
CAS:59831-64-0
Milenperone (R 34009) is a novel anti-invasive compound for the control of behavioral disorders in …
Formula:
C22H23ClFN3O2
Purity:
98.09% - 99.38%
Color and Shape:
Solid
Molecular weight:
415.89
Ref: TM-T25813
1mg | 277.00 € | ||
5mg | 681.00 € | ||
10mg | 931.00 € | ||
25mg | 1,410.00 € | ||
50mg | 1,845.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025